Prognosis
US Inks $25 Million Deal to Fight Ebola With Moderna Technology
- Texas scientists to study vaccines for several deadly viruses
- US is seeking out greater protection from biological threats
This article is for subscribers only.
University of Texas researchers have clinched a US Department of Defense contract worth up to $25 million to develop vaccines using Moderna Inc.’s messenger RNA technology.
Scientists at University of Texas Medical Branch at Galveston, in partnership with Moderna, were awarded $13.5 million over three years to design, manufacture and test mRNA vaccines for Ebola and other lethal pathogens. The project covers the shots’ development through Phase 1 clinical trials and UTMB could receive an additional $11.1 million to study alternative ways of administering the vaccines.